Oxytocic Pharmaceuticals Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Oxytocic Pharmaceuticals Market: By Type (Intramuscular Injection, Intravenous Injection), By Source (Natural Oxytocin (Animal Pituitary Extracts), Synthetic Oxytocin), By End-User (Maternity Clinics, Hospitals) and Geography 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Oxytocic Pharmaceuticals Market size was estimated at USD 196.6 Mn in 2021, growing at a CAGR of 7.2% during the forecast period 2022-2028. Oxytocic Pharmaceutical is a type of medicine that aids in inducing labor pain. It can also be utilized to cure postpartum hemorrhage devices. Oxytocin is the natural hormone on which oxytocic drugs are based. Synthetic oxytocin byproducts are artificial medications. These medications help to progress uterine contractions and can be utilized to cure other situations like obesity and diabetes. The global market provides a detailed overview of the Oxytocic Pharmaceuticals market, and that can be segmented by type, by source, and by the End user. By type, the Oxytocic Pharmaceuticals market has been segmented into Intramuscular Injection and Intravenous Injection. The Intramuscular Injection segment is likely to grow significantly in terms of type. Based on Source, the Oxytocic Pharmaceuticals market is segmented into Natural Oxytocin and Synthetic Oxytocin. Natural oxytocin includes animal pituitary extracts. Among these, the Synthetic Oxytocin segment is expected to have the fastest-growing market during the forecast period 2022-2028. Synthetic oxytocin by-products are artificial forms of the oxytocin hormone. They are made by changing the chemical assembly of natural oxytocin. This modifies the way the hormone functions in the body. Some synthetic oxytocin is utilized to assist pregnant women during childbirth, while others are utilized to cure conditions such as schizophrenia and autism. Based on the End user, the Oxytocic Pharmaceuticals market is segmented into Maternity Clinics and Hospitals. The Hospitals segment is expected to have a significant share in 2021. The use of oxytocin medicinal drugs is not only restricted to hospitals but also to maternity clinics. The drug aids in the easy and smooth delivery of a baby and also supports the initial stages of breastfeeding. It is also utilized to stop bleeding after childbirth. Oxytocin can be given through numerous means, for instance, injections, nasal sprays, and IV drips.

Key Developments:

In December 2020, Iconovo announced its new parthnership with Monash University for the manufacture of inhaled oxytocin ICOone

In August 2022, Tonix Pharmaceuticals announced the Issuance of a U.S. Patent Covering Potentiated Intranasal Oxytocin (TNX-1900) for the pain managemnet

Oxytocic Pharmaceuticals Market

MARKET SUMMARY
-
7.2% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 7.2%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Oxytocic Pharmaceuticals Market

  • The oxytocic pharmaceuticals market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The oxytocic pharmaceuticals market is segmented based on type, source, end user and geography.
Key Players
  • Pfizer, Inc. (U.S.)
  • Fresenius Kabi AG (Germany)
  • Novartis AG (Switzerland)
  • Cardinal Health (U.S.)
Oxytocic Pharmaceuticals Market Drivers

The growing labor induction actions are anticipated to propel the market growth over the forecast years. Moreover, the growing prevalence of postpartum haemorrhage and prequalification from WHO are burgeoning the market growth over the forecast years.


North-America got significant share

Oxytocic Pharmaceuticals Market

North America market is expected to witness the highest market share during the forecast period

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast.
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Oxytocic Pharmaceuticals Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The oxytocic pharmaceuticals market is projected to expand at a CAGR of 7.2% during the forecast period

Pfizer, Inc. (U.S.), Fresenius Kabi AG (Germany), Novartis AG (Switzerland), Cardinal Health (U.S.), Ferring Pharmaceuticals B.V. (Switzerland), Par Pharmaceutical, Inc. (U.S.)

North America is the fastest-growing region for oxytocic pharmaceuticals market


Report

Table Of Content


Report

Company Profile

  • Pfizer, Inc. (U.S.)
  • Fresenius Kabi AG (Germany)
  • Novartis AG (Switzerland)
  • Cardinal Health (U.S.)
  • Ferring Pharmaceuticals B.V. (Switzerland)
  • Par Pharmaceutical, Inc. (U.S.)

Description

Oxytocic Pharmaceuticals Market size was estimated at USD 196.6 Mn in 2021, growing at a CAGR of 7.2% during the forecast period 2022-2028. Oxytocic Pharmaceutical is a type of medicine that aids in inducing labor pain. It can also be utilized to cure postpartum hemorrhage devices. Oxytocin is the natural hormone on which oxytocic drugs are based. Synthetic oxytocin byproducts are artificial medications. These medications help to progress uterine contractions and can be utilized to cure other situations like obesity and diabetes. The global market provides a detailed overview of the Oxytocic Pharmaceuticals market, and that can be segmented by type, by source, and by the End user. By type, the Oxytocic Pharmaceuticals market has been segmented into Intramuscular Injection and Intravenous Injection. The Intramuscular Injection segment is likely to grow significantly in terms of type. Based on Source, the Oxytocic Pharmaceuticals market is segmented into Natural Oxytocin and Synthetic Oxytocin. Natural oxytocin includes animal pituitary extracts. Among these, the Synthetic Oxytocin segment is expected to have the fastest-growing market during the forecast period 2022-2028. Synthetic oxytocin by-products are artificial forms of the oxytocin hormone. They are made by changing the chemical assembly of natural oxytocin. This modifies the way the hormone functions in the body. Some synthetic oxytocin is utilized to assist pregnant women during childbirth, while others are utilized to cure conditions such as schizophrenia and autism. Based on the End user, the Oxytocic Pharmaceuticals market is segmented into Maternity Clinics and Hospitals. The Hospitals segment is expected to have a significant share in 2021. The use of oxytocin medicinal drugs is not only restricted to hospitals but also to maternity clinics. The drug aids in the easy and smooth delivery of a baby and also supports the initial stages of breastfeeding. It is also utilized to stop bleeding after childbirth. Oxytocin can be given through numerous means, for instance, injections, nasal sprays, and IV drips.

Key Developments:

In December 2020, Iconovo announced its new parthnership with Monash University for the manufacture of inhaled oxytocin ICOone

In August 2022, Tonix Pharmaceuticals announced the Issuance of a U.S. Patent Covering Potentiated Intranasal Oxytocin (TNX-1900) for the pain managemnet

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX